NCT05958901Recruiting
Pulmonary Hypertension Observational Study
A Observational Study in Chinese Patients With Pulmonary Hypertension (PH)
Source: ClinicalTrials.gov · Last updated 25 Jul 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The purpose of this study is to establish the large PH cohort and biological database in China, aiming for precision medicine to optimize diagnosis and treatment choices.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 10000 (estimated)
- First submitted
- 12 Jul 2023
- Start date
- 12 Jul 2023
- Primary completion date
- 30 Dec 2025
- Lead sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- NCT number
- NCT05958901
What you commit to
- Study type: Observational
- Planned participants: 10000
- From 12 Jul 2023 to the primary completion date, 30 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Eye surgery in the last three months.
Other illness
- Acute exacerbation in the past 3 months Having other respiratory diseases with massive lung tissue destruction such as severe bronchiectasis and tuberculosis, etc.
- Serious uncontrolled diseases thoracic or abdominal surgery in the last 3 months.
- Retinal detachment myocardial infarction in the last 3 months.
- Admission to hospital for any cardiac condition in the last month.
- Heart rate over 120 beats per minute.
- Antibacterial chemotherapy for tuberculosis pregnant or breast feeding.
Who the study is looking for
- PH group: When the mean pulmonary artery pressure is greater than 25mmHg at rest or greater than 30mmHg during exercise.
- Signed informed consent obtained prior to participations with the ability to comply with protocol and be available for study visits over 5 years.
Age in the registry: 20 years to 70 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The First Affiliated Hospital of Guangzhou Medical University Coordinator of this site? Confirm its status | Guangzhou | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.